These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 25631332)
1. Pharmacological methyl group donors block skeletal metastasis in vitro and in vivo. Shukeir N; Stefanska B; Parashar S; Chik F; Arakelian A; Szyf M; Rabbani SA Br J Pharmacol; 2015 Jun; 172(11):2769-81. PubMed ID: 25631332 [TBL] [Abstract][Full Text] [Related]
2. S-adenosylmethionine blocks osteosarcoma cells proliferation and invasion in vitro and tumor metastasis in vivo: therapeutic and diagnostic clinical applications. Parashar S; Cheishvili D; Arakelian A; Hussain Z; Tanvir I; Khan HA; Szyf M; Rabbani SA Cancer Med; 2015 May; 4(5):732-44. PubMed ID: 25619880 [TBL] [Abstract][Full Text] [Related]
3. Treatment of prostate cancer cells with S-adenosylmethionine leads to genome-wide alterations in transcription profiles. Schmidt T; Leha A; Salinas-Riester G Gene; 2016 Dec; 595(2):161-167. PubMed ID: 27688072 [TBL] [Abstract][Full Text] [Related]
4. SKI-606 (Bosutinib) blocks prostate cancer invasion, growth, and metastasis in vitro and in vivo through regulation of genes involved in cancer growth and skeletal metastasis. Rabbani SA; Valentino ML; Arakelian A; Ali S; Boschelli F Mol Cancer Ther; 2010 May; 9(5):1147-57. PubMed ID: 20423991 [TBL] [Abstract][Full Text] [Related]
5. Alteration of the methylation status of tumor-promoting genes decreases prostate cancer cell invasiveness and tumorigenesis in vitro and in vivo. Shukeir N; Pakneshan P; Chen G; Szyf M; Rabbani SA Cancer Res; 2006 Sep; 66(18):9202-10. PubMed ID: 16982764 [TBL] [Abstract][Full Text] [Related]
6. Influence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer. Feeley BT; Gamradt SC; Hsu WK; Liu N; Krenek L; Robbins P; Huard J; Lieberman JR J Bone Miner Res; 2005 Dec; 20(12):2189-99. PubMed ID: 16294272 [TBL] [Abstract][Full Text] [Related]
7. Overexpression of noggin inhibits BMP-mediated growth of osteolytic prostate cancer lesions. Feeley BT; Krenek L; Liu N; Hsu WK; Gamradt SC; Schwarz EM; Huard J; Lieberman JR Bone; 2006 Feb; 38(2):154-66. PubMed ID: 16126463 [TBL] [Abstract][Full Text] [Related]
8. S-adenosylmethionine, a methyl donor, up regulates tissue inhibitor of metalloproteinase-2 in colorectal cancer. Hussain Z; Khan MI; Shahid M; Almajhdi FN Genet Mol Res; 2013 Apr; 12(2):1106-18. PubMed ID: 23661436 [TBL] [Abstract][Full Text] [Related]
9. LRP5 knockdown: effect on prostate cancer invasion growth and skeletal metastasis in vitro and in vivo. Rabbani SA; Arakelian A; Farookhi R Cancer Med; 2013 Oct; 2(5):625-35. PubMed ID: 24403228 [TBL] [Abstract][Full Text] [Related]
10. DNA methylation regulates expression of VEGF-C, and S-adenosylmethionine is effective for VEGF-C methylation and for inhibiting cancer growth. Da MX; Zhang YB; Yao JB; Duan YX Braz J Med Biol Res; 2014 Dec; 47(12):1021-8. PubMed ID: 25387667 [TBL] [Abstract][Full Text] [Related]
11. RANKL acts directly on RANK-expressing prostate tumor cells and mediates migration and expression of tumor metastasis genes. Armstrong AP; Miller RE; Jones JC; Zhang J; Keller ET; Dougall WC Prostate; 2008 Jan; 68(1):92-104. PubMed ID: 18008334 [TBL] [Abstract][Full Text] [Related]
12. An anti-urokinase plasminogen activator receptor antibody (ATN-658) blocks prostate cancer invasion, migration, growth, and experimental skeletal metastasis in vitro and in vivo. Rabbani SA; Ateeq B; Arakelian A; Valentino ML; Shaw DE; Dauffenbach LM; Kerfoot CA; Mazar AP Neoplasia; 2010 Oct; 12(10):778-88. PubMed ID: 20927316 [TBL] [Abstract][Full Text] [Related]
13. S-adenosylmethionine in combination with decitabine shows enhanced anti-cancer effects in repressing breast cancer growth and metastasis. Mahmood N; Arakelian A; Cheishvili D; Szyf M; Rabbani SA J Cell Mol Med; 2020 Sep; 24(18):10322-10337. PubMed ID: 32720467 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of STAT3 prevents bone metastatic progression of prostate cancer in vivo. Thulin MH; Määttä J; Linder A; Sterbova S; Ohlsson C; Damber JE; Widmark A; Persson E Prostate; 2021 Jun; 81(8):452-462. PubMed ID: 33822400 [TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of S-adenosylmethionine on the growth of human gastric cancer cells in vivo and in vitro. Zhao Y; Li JS; Guo MZ; Feng BS; Zhang JP Chin J Cancer; 2010 Aug; 29(8):752-60. PubMed ID: 20663323 [TBL] [Abstract][Full Text] [Related]
16. Celastrol, an active constituent of the TCM plant Tripterygium wilfordii Hook.f., inhibits prostate cancer bone metastasis. Kuchta K; Xiang Y; Huang S; Tang Y; Peng X; Wang X; Zhu Y; Li J; Xu J; Lin Z; Pan T Prostate Cancer Prostatic Dis; 2017 Jun; 20(2):156-164. PubMed ID: 28195223 [TBL] [Abstract][Full Text] [Related]
17. Potential Implication of Paxillin in Cancer Establishment Within the Bone Environment. Sobkowicz AD; Sanders AJ; Mason MD; Jiang WG Anticancer Res; 2017 Aug; 37(8):4255-4268. PubMed ID: 28739717 [TBL] [Abstract][Full Text] [Related]
18. Reversal of the hypomethylation status of urokinase (uPA) promoter blocks breast cancer growth and metastasis. Pakneshan P; Szyf M; Farias-Eisner R; Rabbani SA J Biol Chem; 2004 Jul; 279(30):31735-44. PubMed ID: 15150277 [TBL] [Abstract][Full Text] [Related]
19. S-adenosylmethionine mediates inhibition of inflammatory response and changes in DNA methylation in human macrophages. Pfalzer AC; Choi SW; Tammen SA; Park LK; Bottiglieri T; Parnell LD; Lamon-Fava S Physiol Genomics; 2014 Sep; 46(17):617-23. PubMed ID: 25180283 [TBL] [Abstract][Full Text] [Related]
20. Quercetin inhibits invasion, migration and signalling molecules involved in cell survival and proliferation of prostate cancer cell line (PC-3). Senthilkumar K; Arunkumar R; Elumalai P; Sharmila G; Gunadharini DN; Banudevi S; Krishnamoorthy G; Benson CS; Arunakaran J Cell Biochem Funct; 2011 Mar; 29(2):87-95. PubMed ID: 21308698 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]